Alzheimer`s could be predicted years before symptoms develop
Many of the biomarkers for Alzheimer`s disease that could potentially predict which patients will develop the disorder later in life have already been identified.
|Last Updated: May 15, 2013, 02:33 PM IST|Source: Bureau
Washington: Many of the biomarkers for Alzheimer`s disease that could potentially predict which patients will develop the disorder later in life have already been identified.
Now, studying spinal fluid samples and health data from 201 research participants at the Charles F. and Joanne Knight Alzheimer`s Disease Research Center, scientists at Washington University School of Medicine in St. Louis have shown the markers are accurate predictors of Alzheimer`s years before symptoms develop.
The researchers evaluated markers such as the buildup of amyloid plaques in the brain, newly visible thanks to an imaging agent developed in the last decade; levels of various proteins in the cerebrospinal fluid, such as the amyloid fragments that are the principal ingredient of brain plaques; and the ratios of one protein to another in the cerebrospinal fluid, such as different forms of the brain cell structural protein tau.
The markers were studied in volunteers whose ages ranged from 45 to 88. On average, the data available on study participants spanned four years, with the longest recorded over 7.5 years.
The researchers found that all of the markers were equally good at identifying subjects who were likely to develop cognitive problems and at predicting how soon they would become noticeably impaired.
Next, the scientists paired the biomarkers data with demographic information, testing to see if sex, age, race, education and other factors could improve their predictions.
"Sex, age and race all helped to predict who would develop cognitive impairment," said Catherine Roe, PhD, research assistant professor of neurology.
"Older participants, men and African Americans were more likely to become cognitively impaired than those who were younger, female and Caucasian," she added.
Roe described the findings as providing more evidence that scientists can detect Alzheimer`s disease years before memory loss and cognitive decline become apparent.
"We can better predict future cognitive impairment when we combine biomarkers with patient characteristics. Knowing how accurate biomarkers are is important if we are going to some day be able to treat Alzheimer`s before symptoms and slow or prevent the disease," she said.
Clinical trials are already underway at Washington University and elsewhere to determine if treatments prior to symptoms can prevent or delay inherited forms of Alzheimer`s disease. Reliable biomarkers for Alzheimer`s should one day make it possible to test the most successful treatments in the much more common sporadic forms of Alzheimer`s.
The study, supported in part by the National Institute on Aging, appears in Neurology.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.